[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017-2022 United States Alzheimer’s Disease Drug Market Report (Status and Outlook)

November 2017 | 119 pages | ID: 29BA85AE07AEN
LP Information

US$ 3,360.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In 2016, the Alzheimer’s Disease Drug market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.

In United States market, the top players include
  • Allergan
  • Eisai
  • Novartis
  • Daiichi Sankyo
  • Merz Pharma
  • Pfizer
  • Johnson & Johnson
  • Lundbeck.
Split by product types/category, covering
  • Donepezil
  • Memantine
  • Rivastigmine
Split by applications/end use industries, covers
  • Early to Moderate Stages
  • Moderate to Severe Stages
1 ALZHEIMER’S DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Alzheimer’s Disease Drug
1.2 Alzheimer’s Disease Drug Market Segment by Types
  1.2.1 United States Alzheimer’s Disease Drug Sales Present Situation and Outlook by Types (2012-2022)
  1.2.2 United States Alzheimer’s Disease Drug Sales Market Share by Types in 2016
  1.2.3 Donepezil
    1.2.3.1 Major Players of Donepezil
  1.2.4 Memantine
    1.2.4.1 Major Players of Memantine
  1.2.5 Rivastigmine
    1.2.5.1 Major Players of Rivastigmine
1.3 United States Alzheimer’s Disease Drug Market Segment by Applications/End Use Industries
  1.3.1 United States Alzheimer’s Disease Drug Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
  1.3.2 United States Alzheimer’s Disease Drug Sales Market Share by Applications in 2016
  1.3.2 Early to Moderate Stages
  1.3.3 Moderate to Severe Stages
1.4 United States Alzheimer’s Disease Drug Overview and Market Size (Value) (2012-2022)
  1.4.1 United States Market Alzheimer’s Disease Drug Overview
  1.4.2 United States Alzheimer’s Disease Drug Market Size (Value and Volume) Status and Forecast (2012-2022)

2 UNITED STATES ALZHEIMER’S DISEASE DRUG SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 United States Alzheimer’s Disease Drug Sales and Market Share (2012-2017) by Players
2.2 United States Alzheimer’s Disease Drug Revenue and Market Share by Players (2012-2017)
2.3 United States Alzheimer’s Disease Drug Average Price by Players in 2016
2.4 United States Alzheimer’s Disease Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Alzheimer’s Disease Drug Market Competitive Situation and Trends
  2.5.1 Alzheimer’s Disease Drug Market Concentration Rate
  2.5.2 Alzheimer’s Disease Drug Market Share of Top 3 and Top 5 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ALZHEIMER’S DISEASE DRUG SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

3.1 United States Alzheimer’s Disease Drug Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.1.1 United States Alzheimer’s Disease Drug Sales and Market Share by Type (2012-2017)
  3.1.2 United States Alzheimer’s Disease Drug Revenue and Market Share by Type (2012-2017)
  3.1.3 United States Alzheimer’s Disease Drug Price by Type (2012-2017)
3.2 United States Alzheimer’s Disease Drug Sales and Market Share by Application (2012-2017)
3.3 United States Market Alzheimer’s Disease Drug Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

4 UNITED STATES ALZHEIMER’S DISEASE DRUG PLAYERS PROFILES AND SALES DATA

4.1 Allergan
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Allergan Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
  4.1.5 Allergan News
4.2 Eisai
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Eisai Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
  4.2.5 Eisai News
4.3 Novartis
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 Novartis Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
  4.3.5 Novartis News
4.4 Daiichi Sankyo
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Daiichi Sankyo Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
  4.4.5 Daiichi Sankyo News
4.5 Merz Pharma
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 Merz Pharma Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
  4.5.5 Merz Pharma News
4.6 Pfizer
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Pfizer Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
  4.6.5 Pfizer News
4.7 Johnson & Johnson
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 Johnson & Johnson Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
  4.7.5 Johnson & Johnson News
4.8 Lundbeck.
  4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.8.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.8.2.1 Type
    4.8.2.2 Type
  4.8.3 Lundbeck. Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.8.4 Main Business/Business Overview
  4.8.5 Lundbeck. News

5 UNITED STATES ALZHEIMER’S DISEASE DRUG MARKET FORECAST (2017-2022)

5.1 United States Alzheimer’s Disease Drug Sales, Revenue and Price Forecast (2017-2022)
  5.1.1 United States Alzheimer’s Disease Drug Sales and Growth Rate Forecast (2017-2022)
  5.1.2 United States Alzheimer’s Disease Drug Revenue and Growth Rate Forecast (2017-2022)
  5.1.3 United States Alzheimer’s Disease Drug Price Trend Forecast (2017-2022)
5.2 United States Alzheimer’s Disease Drug Sales Forecast by Type (2017-2022)
5.3 United States Alzheimer’s Disease Drug Sales Forecast by Application (2017-2022)

6 PRODUCTION COST ANALYSIS OF ALZHEIMER’S DISEASE DRUG

6.1 Main Raw Materials of Alzheimer’s Disease Drug
  6.1.1 List of Alzheimer’s Disease Drug Main Raw Materials
  6.1.2 Alzheimer’s Disease Drug Main Raw Materials Price Analysis
  6.1.3 Alzheimer’s Disease Drug Raw Materials Major Suppliers
  6.1.4 Alzheimer’s Disease Drug Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Alzheimer’s Disease Drug
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Production Expenses
6.3 Alzheimer’s Disease Drug Manufacturing Process/Method

7 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

7.1 Alzheimer’s Disease Drug Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Alzheimer’s Disease Drug Major Players in 2016
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Sales Channel
  8.1.1 Direct Sales
  8.1.2 Indirect Sales
  8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Alzheimer’s Disease Drug Distributors/Traders List in United States

9 MARKET INFLUENCES FACTORS ANALYSIS

9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Data Source
LIST OF TABLES AND FIGURES

Figure Picture of Alzheimer’s Disease Drug
Table Product Specifications of Alzheimer’s Disease Drug
Figure United States Alzheimer’s Disease Drug Sales (volume) for Each Type (2012-2022)
Figure United States Alzheimer’s Disease Drug Sales Market Share by Types in 2016
Table Types of Alzheimer’s Disease Drug
Figure Product Picture of Donepezil
Table Major Players of Donepezil
Figure Product Picture of Memantine
Table Major Players of Memantine
Figure Product Picture of Rivastigmine
Table Major Players of Rivastigmine
Figure United States Alzheimer’s Disease Drug Sales Present Situation and Outlook by Applications (2012-2022)
Figure United States Alzheimer’s Disease Drug Sales Market Share by Applications in 2016
Table Applications of Alzheimer’s Disease Drug
Figure Early to Moderate Stages Examples
Figure Moderate to Severe Stages Examples
Figure United States Alzheimer’s Disease Drug Revenue (Million USD) Status and Forecast (2012-2022)
Figure United States Alzheimer’s Disease Drug Sales (Volume) Status and Forecast (2012-2022)
Table United States Alzheimer’s Disease Drug Sales by Players (2012-2017)
Table United States Alzheimer’s Disease Drug Sales Market Share (%) by Players (2012-2017)
Figure United States Alzheimer’s Disease Drug Sales Share by Players in 2016
Figure United States Alzheimer’s Disease Drug Sales Share by Players in 2017
Table United States Alzheimer’s Disease Drug Revenue (Million USD) by Players (2012-2017)
Table United States Alzheimer’s Disease Drug Revenue Market Share (%) by Players (2012-2017)
Figure United States Alzheimer’s Disease Drug Revenue Share by Players in 2016
Figure United States Alzheimer’s Disease Drug Revenue Share by Players in 2017
Figure United States Alzheimer’s Disease Drug Average Price by Players in 2016
Table United States Alzheimer’s Disease Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Alzheimer’s Disease Drug Product Types
Figure Alzheimer’s Disease Drug Market Share of Top 3 Players
Figure Alzheimer’s Disease Drug Market Share of Top 5 Players
Table United States Alzheimer’s Disease Drug Sales by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Figure United States Alzheimer’s Disease Drug Sales Market Share by Type 2016
Figure 2016 United States Alzheimer’s Disease Drug Sales Market Share by Type
Table United States Alzheimer’s Disease Drug Revenue (Million USD) by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Revenue Market Share by Type (2012-2017)
Figure United States Alzheimer’s Disease Drug Revenue Market Share by Type 2016
Figure 2016 United States Alzheimer’s Disease Drug Revenue Market Share by Type
Table United States Alzheimer’s Disease Drug Price by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Sales by Application (2012-2017)
Table United States Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Figure 2016 United States Alzheimer’s Disease Drug Sales Market Share by Application
Table United States Market Alzheimer’s Disease Drug Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Allergan Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Alzheimer’s Disease Drug Market Share (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Alzheimer’s Disease Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Alzheimer’s Disease Drug Market Share (2012-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daiichi Sankyo Alzheimer’s Disease Drug Market Share (2012-2017)
Table Merz Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merz Pharma Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merz Pharma Alzheimer’s Disease Drug Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Alzheimer’s Disease Drug Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Alzheimer’s Disease Drug Market Share (2012-2017)
Table Lundbeck. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lundbeck. Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lundbeck. Alzheimer’s Disease Drug Market Share (2012-2017)
Figure United States Alzheimer’s Disease Drug Sales and Growth Rate Forecast (2017-2022)
Figure United States Alzheimer’s Disease Drug Revenue and Growth Rate Forecast (2017-2022)
Figure United States Alzheimer’s Disease Drug Price Trend Forecast (2017-2022)
Table United States Alzheimer’s Disease Drug Sales Forecast by Type (2017-2022)
Figure United States Alzheimer’s Disease Drug Sales Market Share Forecast by Type (2017-2022)
Figure United States Alzheimer’s Disease Drug Sales Market Share Forecast by Type in 2022
Table United States Alzheimer’s Disease Drug Sales Forecast by Application (2017-2022)
Figure United States Alzheimer’s Disease Drug Sales Market Share Forecast by Application (2017-2022)
Figure United States Alzheimer’s Disease Drug Sales Market Share Forecast by Application in 2022
Table Production Base and Market Concentration Rate of Raw Material
Figure Alzheimer’s Disease Drug Main Raw Materials Price Trend
Table Alzheimer’s Disease Drug Raw Materials Major Suppliers List
Figure Production Cost Structure of Alzheimer’s Disease Drug
Figure Alzheimer’s Disease Drug Manufacturing Process/Method
Figure Alzheimer’s Disease Drug Value Chain Analysis
Table Raw Materials Sources of Alzheimer’s Disease Drug Major Players in 2016
Table Major Buyers of Alzheimer’s Disease Drug
Table Alzheimer’s Disease Drug Distributors/Traders List in United States


More Publications